MD970143A - Compoziţie farmaceutică - Google Patents

Compoziţie farmaceutică

Info

Publication number
MD970143A
MD970143A MD97-0143A MD970143A MD970143A MD 970143 A MD970143 A MD 970143A MD 970143 A MD970143 A MD 970143A MD 970143 A MD970143 A MD 970143A
Authority
MD
Moldova
Prior art keywords
pharmaceutical composition
clamed
narcolepsy
harmless
particles
Prior art date
Application number
MD97-0143A
Other languages
English (en)
Russian (ru)
Inventor
Peter E. Grebow
Vincent Corvari
David Stong
Original Assignee
Cephalon, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23240954&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MD970143(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cephalon, Inc. filed Critical Cephalon, Inc.
Publication of MD970143A publication Critical patent/MD970143A/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

Este revendicată compoziţia farmaceutică care conţine modafinil sub formă de particule de o anumită mărime, care este eficace şi inofensivă în tratamentul narcolepsiei, hipersomniei idiopatice şi altor forme similare de dereglare a somnului.
MD97-0143A 1994-10-06 1995-10-04 Compoziţie farmaceutică MD970143A (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/319,124 US5618845A (en) 1994-10-06 1994-10-06 Acetamide derivative having defined particle size
PCT/US1995/012944 WO1996011001A1 (en) 1994-10-06 1995-10-04 Modafinil having defined particle size

Publications (1)

Publication Number Publication Date
MD970143A true MD970143A (ro) 1998-12-31

Family

ID=23240954

Family Applications (1)

Application Number Title Priority Date Filing Date
MD97-0143A MD970143A (ro) 1994-10-06 1995-10-04 Compoziţie farmaceutică

Country Status (34)

Country Link
US (2) US5618845A (ro)
EP (3) EP0966962B1 (ro)
JP (1) JP2915146B2 (ro)
KR (1) KR100249360B1 (ro)
AT (3) ATE400260T1 (ro)
AU (1) AU703087B2 (ro)
BG (1) BG62952B1 (ro)
BR (1) BR9509257A (ro)
CA (2) CA2382275C (ro)
CZ (1) CZ291700B6 (ro)
DE (3) DE69535786D1 (ro)
DK (3) DK1088549T3 (ro)
EE (1) EE9700082A (ro)
ES (3) ES2156457T3 (ro)
FI (1) FI121454B (ro)
GB (1) GB2293103B (ro)
GR (2) GR3033152T3 (ro)
HK (3) HK1003561A1 (ro)
HU (1) HU226411B1 (ro)
IS (1) IS1987B (ro)
LT (1) LT4303B (ro)
LV (1) LV11852B (ro)
MD (1) MD970143A (ro)
MX (1) MX9602176A (ro)
NO (1) NO318818B1 (ro)
NZ (1) NZ295869A (ro)
PL (1) PL181523B1 (ro)
PT (3) PT731698E (ro)
RO (1) RO118928B1 (ro)
RU (1) RU2287987C2 (ro)
SI (1) SI9520106B (ro)
SK (1) SK283632B6 (ro)
UA (1) UA42023C2 (ro)
WO (1) WO1996011001A1 (ro)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6821975B1 (en) 1999-08-03 2004-11-23 Lilly Icos Llc Beta-carboline drug products
UA71629C2 (en) * 1999-08-03 2004-12-15 Lilli Icos Llc Composition containing free drug particulate form of ?-carboline (variants), method for its manufacture (variants), and method for treating sexual dysfunction
US6346548B1 (en) 1999-08-16 2002-02-12 Cephalon, Inc. Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
US6455588B1 (en) 1999-08-20 2002-09-24 Cephalon, Inc. Compositions including modafinil for treatment of eating disorders and for appetite stimulation
FR2804322B1 (fr) * 2000-01-31 2002-04-19 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament destine a corriger les troubles de la vigilance associes aux myopathies
US20010034373A1 (en) * 2000-02-09 2001-10-25 Matthew Miller Low dose modafinil for enhancement of cognitive function
US6492396B2 (en) 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
MXPA03000747A (es) * 2000-07-27 2003-06-04 Teva Pharma Modafinilo cristalino y puro y proceso para prepararlo.
AU1167702A (en) * 2000-10-11 2002-04-22 Cephalon Inc Compositions comprising modafinil compounds
US6919378B2 (en) * 2000-10-11 2005-07-19 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
US6489363B2 (en) 2000-10-11 2002-12-03 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
US7749540B2 (en) * 2000-10-11 2010-07-06 Cephalon, Inc. Compositions comprising modafinil compounds
US7141555B2 (en) 2000-12-19 2006-11-28 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US7704975B2 (en) * 2000-12-19 2010-04-27 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
DE60219005T2 (de) * 2001-05-25 2007-12-13 Cephalon, Inc. Modafinil umfassende feste pharmazeutische Formulierungen
US7576133B2 (en) 2002-03-11 2009-08-18 Carl Henry Lawyer Methods and compositions for nasal administration of modafinil
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
AU2003249105A1 (en) 2002-07-08 2004-01-23 Ranbaxy Laboratories Limited Processes for the preparation of oral dosage formulations of modafinil
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
US20080044468A1 (en) * 2002-07-25 2008-02-21 Romi Barat Singh Processes For The Preparation Of Oral Dosage Formulations Of Modafinil
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
US20040116532A1 (en) 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
US20040138180A1 (en) * 2002-10-03 2004-07-15 Barr Laboratories, Inc. Bisphosphonate composition and process for the preparation thereof
IL153098A0 (en) * 2002-11-26 2003-06-24 Chemagis Ltd Pharmaceutical compositions containing modafinil
CA2420180A1 (en) * 2003-02-28 2004-08-28 Bernard Charles Sherman Tablets comprising modafinil
AU2004222307B2 (en) * 2003-03-17 2008-04-17 Neurohealing Pharmaceuticals, Inc. High potency dopaminergic treatment of neurological impairment associated with brain injury
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
EP1477476B1 (en) * 2003-05-16 2009-09-09 Cephalon France Modafinil synthesis process
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US20050137264A1 (en) * 2003-12-22 2005-06-23 Patel Ashish A. Modafinil compositions
EP2292213A1 (en) 2004-02-06 2011-03-09 Cephalon, Inc. Compositions comprising a polymorphic form of armodafinil
US20060024370A1 (en) * 2004-07-29 2006-02-02 Cephalon France Modafinil oral lyophilizate
GT200600008A (es) * 2005-01-18 2006-08-09 Formulacion de compresion directa y proceso
EP1909573A4 (en) * 2005-07-21 2010-09-22 Neurohealing Pharmaceuticals I SHORT-TERM EFFECTIVE MODAFINIL COMPOSITIONS WITH A RAPID INITIAL EFFECT, AND METHOD FOR THEIR USE
US9034381B2 (en) * 2005-11-10 2015-05-19 Alphapharm Pty Ltd Process to control particle size
KR20090031618A (ko) * 2006-07-12 2009-03-26 엘란 코포레이션, 피엘씨 나노입자형 모다피닐 제제
DK2056811T3 (en) 2006-08-14 2018-05-22 Neurohealing Pharmaceuticals Inc Modafinil-based treatment for premature ejaculation
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
JP2010513324A (ja) * 2006-12-21 2010-04-30 アルファファーム ピーティーワイ リミテッド 医薬化合物および医薬組成物
US8173169B2 (en) * 2007-07-11 2012-05-08 Hikma Pharmaceuticals Formulation and process for the preparation of modafinil
US20090325999A1 (en) * 2008-06-27 2009-12-31 Jie Du Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions
AU2009273747A1 (en) * 2008-07-25 2010-01-28 Alphapharm Pty Ltd Atovaquone with a particle size diameter range (D90) of greater than 3 um to about 10 um
US20100036164A1 (en) * 2008-08-06 2010-02-11 Srinivas Areveli Preparation of armodafinil form i
EP2238973A1 (en) 2009-04-07 2010-10-13 Cephalon France Lyophilized preparations of proteasome inhibitors
FR2987267B1 (fr) * 2012-02-28 2015-01-16 Debregeas Et Associes Pharma Application du modafinil dans le traitement de substitution des cacainomanes
FR2987265B1 (fr) * 2012-02-28 2014-02-28 Debregeas Et Associes Pharma Composition pharmaceutique sous forme de sirop a base de modafinil, son procede de fabrication et son application
FR2987266B1 (fr) * 2012-02-28 2014-12-19 Debregeas Et Associes Pharma Procede d'obtention d'une composition pharmaceutique a base de modafinil, composition pharmaceutique ainsi obtenue et son application
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002718A (en) * 1974-10-16 1977-01-11 Arnar-Stone Laboratories, Inc. Gelatin-encapsulated digoxin solutions and method of preparing the same
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
GB1584462A (en) * 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
IT1130924B (it) * 1980-03-06 1986-06-18 Secifarma Spa Procedimento per la preparazione di spironolattone micronizzato
US4600614A (en) * 1983-09-12 1986-07-15 The Dow Chemical Company High-frequency heatable plastics
US4713246A (en) * 1984-03-19 1987-12-15 Bristol-Myers Company Etoposide oral dosage form
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
DE3720493A1 (de) * 1987-06-20 1989-01-26 Nattermann A & Cie Arzneizubereitungen mit mikronisierten ebselen-kristallen
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
JP2642486B2 (ja) * 1989-08-04 1997-08-20 田辺製薬株式会社 難溶性薬物の超微粒子化法
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
FR2684875B1 (fr) * 1991-12-13 1995-05-24 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique.
FR2697162B1 (fr) * 1992-10-23 1995-01-13 Lafon Labor Utilisation du modafinil pour la fabrication d'un médicament pour le traitement de l'incontinence urinaire et des troubles sphinctériens urétro vésicaux.
FR2702968B1 (fr) * 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
DE69431244T2 (de) 1993-04-05 2003-04-17 Sds Pty Ltd Schlagbohrhammer
FR2706767B1 (ro) * 1993-06-22 1995-09-08 Lafon Labor
FR2708201B1 (fr) * 1993-06-30 1995-10-20 Lafon Labor Utilisation de dérivés d'acétamide pour la fabrication de médicaments.
US5493146A (en) 1994-07-14 1996-02-20 Vlsi Technology, Inc. Anti-fuse structure for reducing contamination of the anti-fuse material

Also Published As

Publication number Publication date
BR9509257A (pt) 1998-07-07
FI121454B (fi) 2010-11-30
EP0966962B1 (en) 2001-02-21
AU703087B2 (en) 1999-03-18
AU3951495A (en) 1996-05-02
BG101389A (en) 1997-12-30
ES2156457T3 (es) 2001-06-16
ATE199216T1 (de) 2001-03-15
HU226411B1 (en) 2008-11-28
DE69535786D1 (de) 2008-08-21
ATE400260T1 (de) 2008-07-15
DE69514497D1 (de) 2000-02-17
DE69520161D1 (de) 2001-03-29
SI9520106A (sl) 1998-02-28
PL181523B1 (en) 2001-08-31
GB9524328D0 (en) 1996-01-31
RU2287987C2 (ru) 2006-11-27
JPH09511754A (ja) 1997-11-25
ATE188607T1 (de) 2000-01-15
EP0966962A1 (en) 1999-12-29
FI971417A0 (fi) 1997-04-04
LV11852A (lv) 1997-10-20
GB2293103A (en) 1996-03-20
BG62952B1 (bg) 2000-12-29
RO118928B1 (ro) 2004-01-30
HK1003561A1 (en) 1998-10-30
LT4303B (lt) 1998-03-25
USRE37516E1 (en) 2002-01-15
CA2201967C (en) 2002-12-10
LV11852B (en) 1998-03-20
FI971417A (fi) 1997-04-04
EP0731698B1 (en) 2000-01-12
US5618845A (en) 1997-04-08
EP1088549A1 (en) 2001-04-04
KR100249360B1 (ko) 2000-04-01
HUT77778A (hu) 1998-08-28
LT97060A (en) 1997-10-27
EP1088549B1 (en) 2008-07-09
EE9700082A (et) 1997-10-15
PT966962E (pt) 2001-06-29
ES2142499T3 (es) 2000-04-16
EP0731698A1 (en) 1996-09-18
PT1088549E (pt) 2008-09-23
WO1996011001A1 (en) 1996-04-18
PT731698E (pt) 2000-05-31
UA42023C2 (uk) 2001-10-15
DK1088549T3 (da) 2008-11-17
IS4451A (is) 1997-03-24
PL319480A1 (en) 1997-08-04
NZ295869A (en) 1998-02-26
MX9602176A (es) 1997-05-31
NO971541D0 (no) 1997-04-04
GB2293103B (en) 1997-05-07
JP2915146B2 (ja) 1999-07-05
CZ291700B6 (cs) 2003-05-14
SK283632B6 (sk) 2003-11-04
SK44597A3 (en) 1997-09-10
HK1024625A1 (en) 2000-10-20
SI9520106B (sl) 2003-12-31
DK0731698T3 (da) 2000-05-08
ES2308960T3 (es) 2008-12-16
CA2201967A1 (en) 1996-04-18
GR3035451T3 (en) 2001-05-31
DE69514497T2 (de) 2000-08-10
HK1034676A1 (en) 2001-11-02
CZ103297A3 (en) 1997-09-17
CA2382275A1 (en) 1996-04-18
DK0966962T3 (da) 2001-03-19
CA2382275C (en) 2003-12-16
IS1987B (is) 2005-02-15
GR3033152T3 (en) 2000-08-31
NO318818B1 (no) 2005-05-09
NO971541L (no) 1997-06-04
DE69520161T2 (de) 2001-08-02

Similar Documents

Publication Publication Date Title
MD970143A (ro) Compoziţie farmaceutică
EP0828485A4 (en) USE OF THE R-ENANTIOMER OF N-PROPARGYL-1-AMINOINDANE, ITS SALTS AND COMPOSITIONS
ITMI942025A0 (it) Composizioni farmaceutiche contenenti microorganismi ingegnerizzati e loro uso per terapia
PL323825A1 (en) Peptidyloheterocycli compounds useful in treating diorders associated with thrombosin
HUP0100786A3 (en) Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
HU9303218D0 (en) Application of atp-depended protease and its inhibitor for treatment of cachexy and amyotrophia
BR9504072A (pt) Composiçao farmacêutica métodos para o tratamento de hipercolesterolemia de aterosclerose e kit
ZA989667B (en) The use of MMP-13 selective inhibitors for the treatment of osteoarthritis and other MMP-mediated disorders.
IS4466A (is) Samsetning og meðhöndlun fyrir heila- og mænusigg
IL126109A0 (en) Compositions and use of benzamides and nicotinamides as anti-inflammatory agents
DE69531722D1 (de) Karzinostatische Zusammensetzungen, welche Cis-Oxaliplatin und eine oder mehrere andere verträgliche Karzinostatika enthalten
IL113661A0 (en) Compositions and treatment for multiple sclerosis
PL328833A1 (en) Application of carbonic anhydrase inhibitor in treating the macula oedema
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
PL308245A1 (en) Application of 4'-iodo-4'-desoxydoxorubicine in treating amyloidosis
BR9500886A (pt) Composições com efeito regulador de crescimento e método para o tratamento de culturas
EP1083914A4 (en) TREATING ARTHRITIS AND OTHER SIMILAR DISORDERS
HU9602603D0 (en) Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide derivatives
GB9612990D0 (en) Compositions and methods for the treatment of chronic infections
GB9416340D0 (en) Oil treatment and compositions therefor
ID26079A (id) Budidaya mikroba yang mempunyai aktivitas glutaminase meningkat dan penggunaannya
IL113076A0 (en) Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic aminoacetylmercapto derivatives
SE9401619D0 (sv) New use of fluorocarbon compounds, pharmaceutical composition containing such compounds and method of treatment
BR7201475U (pt) Maquina para fabricacao de absorventes,fraudas e assemelhados
GB2288343B (en) The treatment of gas streams